We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$42.4B
1-Year Est. Return
181.11%
This Fund
S&P 500
This Quarter
Est. Return
+14.73%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$19.8B
AUM Growth
+$4.43B
(+29%)
Cap. Flow
-$459M
Cap. Flow
% of AUM
-2.31%
Top 10 Holdings %
Top 10 Hldgs %
44.52%
Holding
334
New
39
Increased
100
Reduced
95
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$124M |
| 2 |
McKesson
MCK
|
+$123M |
| 3 |
Amazon
AMZN
|
+$72.5M |
| 4 |
Rambus
RMBS
|
+$72.1M |
| 5 |
Indivior Pharmaceuticals
INDV
|
+$69.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$102M |
| 2 |
Teradyne
TER
|
+$90.7M |
| 3 |
Apple
AAPL
|
+$80M |
| 4 |
United Therapeutics
UTHR
|
+$72.6M |
| 5 |
Visa
V
|
+$71.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.14% |
| 2 | Miscellaneous | 28.15% |
| 3 | Healthcare | 17.87% |
| 4 | Financials | 12.12% |
| 5 | Communication Services | 6.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKYA
176
DELISTED
Akoya BioSciences
AKYA
| $11.2M | 0.06% |
1,515,470
+200,000
| +15% | +$1.34M |
|
177
MP Materials
MP
$9.05B
| $11M | 0.06% |
481,500
+147,000
| +44% | +$3.37M |
|
178
Morgan Stanley
MS
$323B
| $10.9M | 0.06% |
127,872
+18,419
| +17% | +$1.58M |
|
179
American Express
AXP
$220B
| $10.7M | 0.05% |
+61,248
| New | +$9.88M |
|
180
Baker Hughes
BKR
$56.6B
| $10.6M | 0.05% |
336,658
| – | – |
|
181
TE Connectivity
TEL
$58.5B
| $10.6M | 0.05% |
75,767
+5,101
| +7% | +$645K |
|
182
JFrog
FROG
$11.5B
| $10.5M | 0.05% |
+380,313
| New | +$8.69M |
|
183
Royal Bank of Canada
RY
$283B
| $10.5M | 0.05% |
109,836
+38,951
| +55% | +$3.72M |
|
184
Norfolk Southern
NSC
$72B
| $10.3M | 0.05% |
45,639
-14,567
| -24% | -$3.09M |
|
|
185
CALL
Microsoft
MSFT
$3.74T
| $9.88M | 0.05% |
29,000
+24,200
| +504% | +$7.58M |
|
186
CALL
X4 Pharmaceuticals
XFOR
$357M
| $9.7M | 0.05% |
+166,667
| New | +$8.56M |
|
187
Stryker
SYK
$107B
| $9.62M | 0.05% |
31,539
| – | – |
|
188
Vertiv
VRT
$93B
| $9.54M | 0.05% |
385,000
-326,000
| -46% | -$5.6M |
|
189
Bio-Rad Laboratories Class A
BIO
$9.88B
| $9.38M | 0.05% |
24,751
-123,156
| -83% | -$50.1M |
|
190
Ovintiv
OVV
$18.4B
| $9.25M | 0.05% |
242,931
-40,457
| -14% | -$1.46M |
|
191
Toronto Dominion Bank
TD
$197B
| $9.01M | 0.05% |
145,343
-79,001
| -35% | -$4.75M |
|
192
PNC Financial Services
PNC
$97.3B
| $8.89M | 0.04% |
70,614
-3,778
| -5% | -$462K |
|
193
Tenet Healthcare
THC
$20.8B
| $8.78M | 0.04% |
107,895
-112,280
| -51% | -$7.99M |
|
194
Qorvo
QRVO
$9.88B
| $8.47M | 0.04% |
83,000
+51,200
| +161% | +$4.91M |
|
195
Rockwell Automation
ROK
$46.2B
| $8.43M | 0.04% |
25,598
| – | – |
|
196
Walmart Inc
WMT
$863B
| $8.24M | 0.04% |
157,332
| – | – |
|
197
Coca-Cola Europacific Partners
CCEP
$45.7B
| $8.14M | 0.04% |
+126,359
| New | +$8.02M |
|
198
Ares Management
ARES
$29.7B
| $7.99M | 0.04% |
82,955
+7,169
| +9% | +$620K |
|
199
MSCI
MSCI
$39.8B
| $7.75M | 0.04% |
16,512
-12,092
| -42% | -$5.9M |
|
200
NIO
NIO
$9.17B
| $7.61M | 0.04% |
785,000
+113,000
| +17% | +$956K |
|
Similar funds
GAM
SAM
Polar Capital Holdings's Q2 2023 Portfolio in Review
As of Q2 2023, Polar Capital Holdings held 334 positions worth $19.8B, up 29% from $15.4B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Polar Capital Holdings's Q2 2023 filing shows 39 new, 100 increased, 95 reduced and 48 closed positions. Its largest new stake was Synopsys: 308,727 shares worth $134M. The largest sale was Microsoft, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 36% a quarter earlier, followed by Miscellaneous and Healthcare.
- Polar Capital Holdings's largest Q2 2023 buy was Synopsys: 308,727 shares worth $134M.
- Polar Capital Holdings added most to Amazon in Q2 2023, an estimated $72.5M increase.
- Polar Capital Holdings's biggest Q2 2023 reduction was Microsoft, cutting an estimated $102M.
- Polar Capital Holdings fully exited Teradyne in Q2 2023, selling an estimated $90.7M.
- Polar Capital Holdings's ten largest holdings make up 45% of its $19.8B portfolio in Q2 2023.
- Polar Capital Holdings opened 39 new positions and closed 48 in Q2 2023.
- Polar Capital Holdings's portfolio value rose 29% quarter-over-quarter to $19.8B.
Based on Polar Capital Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.